无并发症阿米巴肝脓肿的经皮导管引流:导管拔除临床方案的前瞻性评估及残留积液的意义
这项多中心前瞻性研究纳入110例需经皮导管引流的无并发症阿米巴肝脓肿患者,按4项标准(腹痛消失、无发热至少48小时、总白细胞计数改善趋势、引流液<10 ml/天至少连续2天)拔管。62.7%的患者在置管5天内满足全部4项标准(最佳反应),中位5天成功拔管,拔管时97.3%仍有残留积液但无复发;未能在5天内满足全部4项标准者需排查局部和全身并发症。
要点
- 拔管依据临床表现与引流液量,而非影像上残留积液是否消失:拔管时97.3%患者仍有残留积液。
- 置管5天内未满足4项拔管标准者(37.3%)应排查局部和全身并发症。
- 残留积液在拔管后1个月和3个月随访时仍分别见于92.1%和84.9%的可随访患者。
核心结论
- 基于本临床方案,即使存在残留积液,阿米巴肝脓肿的经皮导管引流管拔除仍可成功加速完成。
- 置管5天内未能满足全部4项标准者,需进一步评估需额外治疗措施的局部和全身并发症。
研究设计与样本
- 前瞻性研究,连续纳入来自3家医院的无并发症阿米巴肝脓肿需引流患者,按标准方案管理。
- 共110例患者接受经皮导管引流置管,平均年龄46.6±10.5岁,男性93.6%,酗酒者89.1%。
关键影像表现/征象
- 拔管时97.3%的患者影像上仍可见残留积液。
- 拔管后1个月和3个月可随访患者中,残留积液分别见于92.1%和84.9%。
诊断标准与关键数值
- 拔管需满足全部4项标准:腹痛消失、无发热至少48小时、总白细胞计数呈改善趋势(连续2次报告记录)、导管引流液<10 ml/天至少连续2天。
- 置管5天内满足全部4项标准定义为最佳反应,本组69/110例(62.7%)。
- 未达最佳反应者41/110例(37.3%),其中新发积液5/110例(4.5%)、脓肿破裂2/110例(1.8%)、胆漏3/110例(2.7%)、胆管炎2/110例(1.8%)、血栓性静脉炎2/110例(1.8%)、医院获得性感染2/110例(1.8%)。
- 最终全部患者均成功拔管,中位时间5天(IQR 4-9天)。
临床应用与阅片要点
- 拔管决策可依据腹痛消失、无发热至少48小时、总白细胞计数改善趋势和引流液<10 ml/天至少连续2天,而不必等待影像上残留积液完全消失。
- 置管5天内未满足全部4项标准者,应评估新发积液、脓肿破裂、胆漏、胆管炎、血栓性静脉炎和医院获得性感染等并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Patients with amoebic liver abscess (ALA) may require percutaneous catheter drainage (PCD). Once the PCD output is substantially reduced or has ceased along with clinical recovery, residual collections on radiological evaluation may concern the treating physicians. The prevalence and significance of such collections is unknown, and the subsequent approach how to tackle them is unclear.
METHODS: Consecutive patients with one or more uncomplicated ALAs requiring drainage were prospectively enrolled from 3 hospitals and managed based on a standard approach. Catheter removal was attempted after the patients fulfilled all 4 of the following criteria: disappearance of abdominal pain, absence of fever for at least 48 h, an improving trend of TLC (documented on 2 consecutive reports), and catheter drain output of < 10 ml/day for at least 2 consecutive days.
RESULTS: A total of 110 patients (mean age 46.6 ± 10.5 years, 93.6% males, 89.1% alcoholics) underwent PCD placement; 69 patients (69/110; 62.7%) met all 4 criteria within 5 days of PCD placement (optimal response) and had an uncomplicated course. Patients with suboptimal responses (41/110; 37.3%) were evaluated for local and systemic complications; the appearance of fresh collections (5/110; 4.5%), abscess rupture (2/110; 1.8%), bile leakage (3/110; 2.7%), cholangitis (2/110; 1.8%), thrombophlebitis (2/110; 1.8%) and hospital-acquired infections (2/110; 1.8%) were diagnosed and treated accordingly. Ultimately, PCD removal (based on the fulfilment of all 4 criteria) was universally successful after a median of 5 days (IQR, 4-9 days). None of the patients had symptom recurrence after PCD removal, although residual collections were still seen in 97.3% of patients at the time of PCD removal and in 92.1% and 84.9% of patients available for follow-up at 1 and 3 months, respectively.
CONCLUSION: Based on our clinical protocol, PCD removal in ALA can be successfully expedited even in the presence of residual collections. An inability to fulfill all 4 criteria within 5 days of PCD placement warrants further evaluations for local and systemic complications that require additional therapeutic measures.
引用
- Goyal A, Dhaliwal HS, Nampoothiri RV, et al. Percutaneous catheter drainage of uncomplicated amoebic liver abscess: prospective evaluation of a clinical protocol for catheter removal and the significance of residual collections. Abdom Radiol (NY). 2021. PMID: 33469690. doi:10.1007/s00261-021-02949-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。